Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sass

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Nuklearmedizin. Nuclear Medicine|October 10, 1997
Altered relationships between rCBF in different brain regions of never-treated schizophrenicsO Sabri, R Erkwoh, M Schreckenberger, et al.
Environmental Health Perspectives|August 1, 1990
Genetic and molecular analysis of six tumor suppressor genes in Drosophila melanogasterT Löffler, J Wismar, H Sass, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Nuklearmedizin. Nuclear Medicine|December 30, 1998
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study]M Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Psychiatrische Praxis|January 14, 1999
[Quality indicators of patient treatment of schizophrenic patients. Results of a pilot study for external quality assurance using tracer diagnosis]B Janssen, M Jänner, F Schneider, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|December 29, 2000
[Impulse control and affect regulation in personality disorders]S C Herpertz, H J Kunert, A Schürkens, et al.
European Journal of Nuclear Medicine|November 3, 1998
Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucoseM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Bacteriology|June 28, 2021
Genetic Analysis of DinG Family Helicase YoaA and Its Interaction with Replication Clamp Loader Protein HolC in Escherichia coliVincent A Sutera, Thalia H Sass, Scott E Leonard, et al.
European Journal of Nuclear Medicine|January 19, 2000
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET studyM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Nuklearmedizin. Nuclear Medicine|October 10, 1997
Altered relationships between rCBF in different brain regions of never-treated schizophrenicsO Sabri, R Erkwoh, M Schreckenberger, et al.
Environmental Health Perspectives|August 1, 1990
Genetic and molecular analysis of six tumor suppressor genes in Drosophila melanogasterT Löffler, J Wismar, H Sass, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Nuklearmedizin. Nuclear Medicine|December 30, 1998
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study]M Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Psychiatrische Praxis|January 14, 1999
[Quality indicators of patient treatment of schizophrenic patients. Results of a pilot study for external quality assurance using tracer diagnosis]B Janssen, M Jänner, F Schneider, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|December 29, 2000
[Impulse control and affect regulation in personality disorders]S C Herpertz, H J Kunert, A Schürkens, et al.
European Journal of Nuclear Medicine|November 3, 1998
Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucoseM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Bacteriology|June 28, 2021
Genetic Analysis of DinG Family Helicase YoaA and Its Interaction with Replication Clamp Loader Protein HolC in Escherichia coliVincent A Sutera, Thalia H Sass, Scott E Leonard, et al.
European Journal of Nuclear Medicine|January 19, 2000
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET studyM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Pageof 15